Evidence map›Paper›PMID 42051601›Full record

ReviewFrontiers in rehabilitation sciences2026

Nanomaterial-enabled physical rehabilitation: mechanisms, evidence, and translational pathways.

Sarfaraz K Niazi

Abstract readReview
In one paragraph

Review in Frontiers in rehabilitation sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sarfaraz K NiaziCollege of Pharmacy, University of Illinois, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physical rehabilitation relies on macroscopic therapeutic modalities such as ultrasound, photothermal stimulation, electrical activation, magnetic fields, and controlled mechanical loading to restore function after injury, surgery, or neurological impairment. Although these approaches are clinically established and widely used, their effects remain constrained by limited spatial precision, shallow penetration, heterogeneous tissue responses, and insufficient control over the cellular and molecular mechanisms that govern healing. Advances in nanoscience have introduced a new class of materials capable of mediating, amplifying, or refining external physical stimuli at the nanoscale. Nanomaterials exhibit tunable optical, magnetic, mechanical, and electrical properties that enable the conversion of externally applied energy into localized thermal, mechanical, or electrochemical cues, thereby influencing cellular behavior with a degree of precision not achievable by conventional modalities alone. These properties suggest potential-demonstrated primarily in preclinical models-to improve musculoskeletal repair, modulate nociceptive pathways, enhance neuromuscular activation, and integrate with regenerative scaffolds, though clinical validation remains limited. Yet, despite promising experimental findings, translation into rehabilitation practice remains limited by gaps in mechanistic understanding, variability in experimental design, safety uncertainties, and complex regulatory pathways. This review examines the fundamental properties of nanomaterials relevant to physical rehabilitation, analyzes their interactions with primary therapeutic modalities, evaluates preclinical and early clinical evidence, and outlines translational, safety, and regulatory considerations. By synthesizing mechanistic insight with empirical data, the review defines realistic opportunities and the limitations that must be resolved to advance nanomaterial-enabled physical rehabilitation toward clinical implementation.

Indexed as

magnetic nanoparticlesnanomaterialsneuromodulationphotothermal therapyphysical rehabilitationsonodynamic therapytissue regenerationtranslational nanomedicine

Identifiers

PMID42051601
PMCPMC13111205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.